Učitavanje...
Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
The diagnosis of pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis, in particular, when patients present with unresectable disease. While significant progress has been made in understanding the biology of PDAC, this knowledge has not translated into a clear clinical benefit and curr...
Spremljeno u:
| Izdano u: | Med Sci (Basel) |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635789/ https://ncbi.nlm.nih.gov/pubmed/29099030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci5020014 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|